73 Although renal outcomes did not reach statistical significance, there was a potential benefit in reducing the progression of albuminuria and serious renal outcomes in this trial.
← all excerpts
The contemporary role of sodium-glucose co-transporter 2 inhibitor (SGLT2i) and angiotensin receptor-neprilysin inhibitor (ARNI) in the management of heart failure: State-of-the-art review.
1
—
—